Breaking News
February 23, 2019 - Surprise rheumatoid arthritis discovery points to new treatment for joint inflammation
February 23, 2019 - A just-right fix for a tiny heart
February 23, 2019 - Owlstone Medical and Shanghai Renji Hospital collaborate to initiate breath biopsy lung cancer trial
February 23, 2019 - AMSBIO’s comprehensive portfolio of knock-out cell lines and lysates
February 23, 2019 - New app reliably determines physicians’ skills in forming accurate, efficient diagnoses
February 23, 2019 - Peripheral nerve injury can trigger the onset and spread of ALS, shows study
February 23, 2019 - Researchers uncover mechanisms that prevent tooth replacement in mice
February 23, 2019 - Once-a-day capsule offers new way to reduce symptoms of chronic breathlessness
February 23, 2019 - FDA Adds Boxed Warning for Increased Risk of Death with Gout Medicine Uloric (febuxostat)
February 23, 2019 - Phone-based intervention aids rheumatoid arthritis care
February 23, 2019 - Opioid epidemic makes eastern inroads and targets African-Americans
February 23, 2019 - New identified biomarker predicts patients who might benefit from HER2-targeted agents
February 23, 2019 - Study offers new insights into mechanisms of changes in erythrocytes under stress
February 23, 2019 - Antipsychotic polypharmacy may be beneficial for schizophrenia patients
February 23, 2019 - Researchers investigate how marijuana and tobacco co-use affects quit attempts by smokers
February 23, 2019 - Patients with diabetes mellitus have high risk of stable ischemic heart disease
February 23, 2019 - Transparency on healthcare prices played key role in Arizona health system’s turnaround
February 23, 2019 - A comprehensive, multinational review of peppers around the world
February 23, 2019 - Study finds modest decrease in burnout among physicians
February 23, 2019 - A simple change can drastically reduce unnecessary tests for urinary tract infections
February 23, 2019 - Deep Learning-Enhanced Device Detects Diabetic Retinopathy
February 23, 2019 - Researchers discover new binding partner for amyloid precursor protein
February 23, 2019 - Modest decrease seen in burnout among physicians, researchers say | News Center
February 23, 2019 - Transplanting bone marrow of young mice into old mice prevents cognitive decline
February 23, 2019 - Mogrify to accelerate novel IP and cell therapies using $3.7m USD funding
February 23, 2019 - Johns Hopkins study describes cells that may help speed bone repair
February 23, 2019 - Scientists demonstrate influence of food odors on proteostasis
February 23, 2019 - Researchers unlock the secret behind reproduction of fish called ‘Mary’
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Heart attacks more likely to be fatal in women and rates are rising
February 22, 2019 - Morning walks could be better than drugs at lowering blood pressure
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
Zika virus could become a weapon against brain cancer

Zika virus could become a weapon against brain cancer

image_pdfDownload PDFimage_print

Zika virus infection is a dreaded one that can lead to severe brain damage in the unborn babies of mothers who get it.

In a new research now, scientists from the University of Texas Medical Branch in collaboration with others have found that a modified version of the Zika virus could kill some of the stem cells that let the brain tumour cells live. This was proved to be true in mice and human trials are on the cards say the researchers.

Zika virus is spread by infected mosquito bites and has been causing mental retardation microcephaly (small brain), blindness and other deformities among babies since the 1940s when it was first discovered. It was predominantly seen in Asia, Africa and parts of South and Central America. The last outbreak of this viral flu like illness was noted in 2015 in the Americas. While adults came down with the mild flu like illness, the virus spelled danger to pregnant women, damaging the unborn babies.

Zika virus, a virus which causes Zika fever. Image Credit: Kateryna Kon / Shutterstock

Zika virus, a virus which causes Zika fever. Image Credit: Kateryna Kon / Shutterstock

This new study was led by geneticist Pei-Yong Shi of the University of Texas Medical Branch. This team was looking at Zika virus and its genetically similar cousins to understand the effects of the virus on the brains of unborn babies. They noted that despite being similar to the West Nile virus, Zika infected only a specific fetal brain cell called the neural progenitor cell. This hampers the normal growth of the neurons in the brain and alters the brain development of the baby.

This unique property of Zika virus to target the neuro progenitor cells only was a finding wherein researchers wondered if this could help patients with glioblastoma multiforme (GBM). GBM is a form of incurable brain cancer that has less than 5 percent survival among those affected. These tumours are typically resistant to chemotherapy and radiation and tend to return even after they are eradicated. Researchers noted that this tenacity of the tumours to keep returning is dependent on a special type of stem cell that produces the brain cells called the glioma cells. These glioma cells are similar to the neural progenitor cells that the Zika virus prefers. Shi and his team thus hypothesized that the Zika virus could be modified to kill the glioma cells and thus stop the cancer from returning.

The team then started to work with weakened versions of the Zika virus to see if it could affect the cancer and kill the GBM form of brain tumours in the mice. In other words they developed a vaccine strain of the Zika virus which is much weakened. The mice they tested upon had weakened immune system and the vaccine strain of the Zika virus did not cause any harm. In some of the mice, the GBM was grafted. The vaccine Zika strain seemed to kill of these GBM tumours. As obvious, says Shi, this is the first step and much more work is necessary before the virus strain can be used in patients with GBM. “Nothing is guaranteed, but so far the data is very promising, and we would like to move step-by-step to moving into clinics as soon as possible,” he said.

The results of the study were published in the latest issue of the journal mBio.

Source:

https://mbio.asm.org/content/9/5/e01683-18

Posted in: Medical Research News | Medical Condition News

Tags: Baby, Blindness, Brain, Brain Cancer, Brain Cell, Cancer, Cell, Chemotherapy, Fever, Flu, Glioblastoma, Glioblastoma Multiforme, Glioma, Immune System, Mental Retardation, microcephaly, Mosquito, Neurons, Research, Stem Cell, Vaccine, Virus, West Nile Virus, Zika Virus

Tagged with:

About author

Related Articles